cesargnqg160.currentvale.com

The Economics of a Cash-Pay Telehealth Business

Cash-pay telehealth looks simple on a slide. A patient pays a monthly fee, a provider reviews their case and a pharmacy ships medication. In practice, the margin lives or dies in a handful of numbers most founders do not model until it is too late.

This post walks through those numbers in plain terms. It uses one published pricing model as an example, the Cuvo Health platform, because its fees are public. Use your own vendor quotes when you build your model.

Why cash-pay is different

Cash-pay means patients pay out of pocket rather than through insurance. You avoid claims, coding and long payment delays. You also lose the safety net of insurance coverage, so patients judge your price directly.

Medicare and commercial insurers have their own telehealth rules. The CMS Medicare telehealth page explains coverage on that side. Many direct-to-consumer brands choose to stay cash-pay so they can move faster and keep pricing simple. Confirm with counsel whether any of your patients or services raise insurance-related obligations.

Revenue: what a patient is worth

Start with monthly revenue per active patient. That is your program price, minus refunds and discounts.

Then estimate how many months a typical patient stays. Revenue per month times average months gives you lifetime revenue. This is the single most important number, because it tells you how much you can afford to spend to win each patient.

Retention changes everything. A program that keeps patients twice as long can often afford twice the acquisition cost.

Costs: what each patient costs you

Break costs into buckets.

Clinical and platform costs

  • Per-consult fees for provider reviews
  • Monthly platform subscription
  • One-time setup fees, spread over your first year or two
  • Lab costs if your program requires them

Medication costs

  • The pharmacy price for each fill
  • Any markup the partner adds
  • Cold-chain shipping, if not included

Growth costs

  • Paid ads, creator fees and content
  • Promo discounts

Operating costs

  • Support staff, payment processing, software and legal review

As an example of published numbers, Cuvo lists $25 per completed white label pharmacy telehealth consult, no revenue share and 0% medication markup. Its Launch plan is $997 per month after a $9,800 setup fee, and its Grow plan is $2,500 per month after a $15,000 setup fee. Medication and marketing are extra.

Watch out for revenue share

Some partners take a percentage of revenue instead of, or on top of, fixed fees. Revenue share can feel cheap at the start. As you grow, it can become your largest cost. Always model a vendor's fees at your target volume, not just at launch.

Customer acquisition cost

Customer acquisition cost (CAC) is what you spend to win one paying patient. Add all marketing spend for a period and divide by new paying patients in that period.

A healthy business usually needs lifetime gross margin to be clearly larger than CAC. If it is not, either improve retention, lower acquisition cost or raise prices.

A simple break-even check

Ask three questions:

  1. What is my gross margin per patient per month after clinical, medication and shipping costs?
  2. How many active patients cover my fixed costs, such as the platform fee and team?
  3. How long does it take to earn back CAC?

If the answer to the third question is many months, you will need cash in the bank to fund growth.

Levers that move the numbers

  • Retention. Refill reminders, check-ins and coaching keep patients longer.
  • Conversion. Faster provider review means fewer drop-offs.
  • Pricing clarity. Transparent pricing reduces refunds and chargebacks.
  • Cost visibility. Fees you can predict are easier to plan around.

The bottom line

Cash-pay telehealth can be a strong business, but only if the unit economics hold. Model lifetime revenue, all-in costs and CAC before you scale. Compare vendors at your real volume, and keep your claims and pricing honest. Good numbers make good decisions much easier.